Our History
A Forerunner Advancing Innovation in Life Science
  • 2021
    Vazyme went public on the star market of the Shanghai Stock Exchange under the stock code 688105.
  • 2020
    COVID-19 Solutions with high detection sensitivity were developed by Vazyme professional team and certified by more and more regions from all over the world.
  • 2019
    Several key projects of Vazyme Medical passed the External Quality Assessment (EQA) of the National Center for Clinical Laboratories with full marks.
  • 2016
    Vazyme Medical Technology CO., LTD was established, which aimed to deploy IVD testing reagents and instruments.
  • 2015
    The International Business Department was set up with the belief of becoming the professional supplier of In Vitro Diagnostic Solutions worldwide.
  • 2012
    Vazyme was established including a number of biomolecular research reagent product lines with independent intellectual property rights

Subscribe to our Newsletter

Our vision is to lead in biotechnology by driving innovation relentlessly, pursuing the highest standards in quality of products and services, and creating value for our customers.




Address: Building D2, Hongfeng science and
Technology Park, Kechuang Road, Nanjing
Economic and Technological Development
Zone, Jiangsu Province, China
Tel:+86 400-969-0586
E-mail: service.medical@vazyme.com
Copyright @ 2022 Nanjing Vazyme Biotech Co.,Ltd. All Rights Reserved